.
BM212-derived MmpL3 inhibitors enabling new possibilities for the treatment of TB and studies of mycobacterial iron assimilation as new potential target for drug discovery / Alfonso, Salvatore. - (2013 Sep 10).
BM212-derived MmpL3 inhibitors enabling new possibilities for the treatment of TB and studies of mycobacterial iron assimilation as new potential target for drug discovery
ALFONSO, SALVATORE
10/09/2013
Abstract
.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.